Search Medical Condition
Please enter condition
Please choose location

Oral Medicine Clinical Trials

A listing of Oral Medicine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (103) clinical trials

Patient Inclusion Criteria: 18+ years of age Diagnosis of stable plaque psoriasis Moderate to severe Covering at least 10% of total body surface area Patient Exclusion Criteria: Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular psoriasis

Phase

The purpose of the study is to evaluate the effectiveness of two dosing regimens of Investigational Product (Oral Agent) compared to placebo, in patients with rheumatoid arthritis (RA). Patient Inclusion Criteria: Active rheumatoid arthritis (RA) diagnosed after the age of 16 6 or more swollen joints and 6 or more ...

Phase

If you are a man or woman over the age of 18, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational form of insulin to reduce blood sugar levels in individuals with Type 2 Diabetes. There is no cost to ...

Phase N/A

Gotta Go? Gotta Go? Gotta Go? Qualified participants will receive at no cost study related exams and investigational overactive bladder medication. Males or females that are 18 or older and have bothersome urinary frequency and urgency may qualify for participation. Compensation is available for time and travel.

Phase N/A

Are you a Diabetic taking Metformin? Are you also taking other diabetic oral medications? If yes, you may be eligible for a clinical research study testing an investigational medication for diabetes. If you meet the study criteria you will receive study related care from a team of doctors and nurses, ...

Phase

Do you have multiple sclerosis? Meridien Research is seeking research volunteers for a clinical study of an oral MS medication.

Phase N/A

This study evaluates the efficacy of TAK-385 for achieving and maintaining testosterone suppression. Evaluates the safety and tolerability of TAK-385, evaluates the efficacy for prostate specific antigen (PSA) lowering. This study also evaluates the quality of life related to androgen deprivation and recovery from androgen deprivation therapy using validated patient-reported ...

Phase

Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard diuretic and comorbidity treatment for heart failure with preserved ejection fraction (HFpEF).

Phase N/A

The purpose of this study is to see if selegiline and tadalafil (generic for Cialis®) results in an improvement in Erectile dysfunction (ED) in male patients with Parkinson's disease (PD) and moderate ED. Male PD patients who have an incomplete response to tadalafil alone will be given both medications to ...

Phase

MGCD265 belongs to a new class of drugs with anticancer potential, known as tyrosine kinase inhibitors. MGCD265 was shown to slow down the growth of human cancer cells in mice. Clinical studies are being pursued to evaluate the safety of MGCD265 in cancer patients. In this study, MGCD265 is orally ...

Phase